Search - tctmd.com

Displaying 181 - 200 of 237

Sort: Relevancy | Date

News Conference News ESC 2016

Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4

Todd Neale

August 31, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients

Todd Neale

July 29, 2016

News Daily News

FDA: No More Chances for Embattled Coagulation Monitoring System

Todd Neale

July 13, 2016

News Daily News

FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación

Todd Neale

July 13, 2016

News Daily News

ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device

Todd Neale

July 08, 2016

News Daily News

Sigue Abusándose de la Aspirina como Protección Única frente a los ACV en Pacientes con FA

Todd Neale

June 27, 2016

News Daily News

Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib

Todd Neale

June 27, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

News Daily News

Rivaroxaban podría Ayudar a Disolver Trombos Auriculares Izdos. en Pacientes con FA

Todd Neale

June 09, 2016

News Daily News

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

Todd Neale

June 09, 2016

News Daily News

Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA

Todd Neale

April 21, 2016

News Daily News

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Todd Neale

April 21, 2016

News Conference News ACC 2016

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

Todd Neale

April 06, 2016

News Daily News

La FDA Aborda Cuestiones Regulatorias y Científicas con Dispositivos Portátiles para la Monitorización de la Coagulación

Todd Neale

March 24, 2016

News Daily News

FDA Tackles Regulatory, Scientific Issues With Point-of-Care Coagulation Monitoring Devices

Todd Neale

March 24, 2016

News Daily News

US Cardiologists Are Underusing Oral Anticoagulation for A-fib

Todd Neale

March 21, 2016

News Daily News

Los Cardiólogos de EE.UU. Infrautilizan la Anticoagulación Oral en el Manejo de la FA

Todd Neale

March 21, 2016

News Daily News

Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina

Todd Neale

March 01, 2016

Advertisement

Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients

FDA: No More Chances for Embattled Coagulation Monitoring System

FDA: No Más Oportunidades para el Acosado Sistema para Monitorizar la Coagulación

ROCKET AF Investigators Respond to New Questions About Point-of-Care Warfarin Monitoring Device

Sigue Abusándose de la Aspirina como Protección Única frente a los ACV en Pacientes con FA

Aspirin as Standalone Stroke Protection Still Overused for Patients With A-fib

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Rivaroxaban podría Ayudar a Disolver Trombos Auriculares Izdos. en Pacientes con FA

Rivaroxaban May Help Dissolve Left Atrial Thrombus in Patients With A-fib

Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA

Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib

Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding

La FDA Aborda Cuestiones Regulatorias y Científicas con Dispositivos Portátiles para la Monitorización de la Coagulación

FDA Tackles Regulatory, Scientific Issues With Point-of-Care Coagulation Monitoring Devices

US Cardiologists Are Underusing Oral Anticoagulation for A-fib

Los Cardiólogos de EE.UU. Infrautilizan la Anticoagulación Oral en el Manejo de la FA

Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content